Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

SEALSQ Corporation (LAES)

3,20

-0,45

(-12,33%)

Fermé 06 Juin 10:00PM

3,19

-0,01

(-0,31%)

Après les heures de négociation: 1:58AM

SEALSQ Corporation ([symbol]) Options

LAES Flux des options

Achats

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
0,50	2,23	3,55	2,88	2,89	0,00	0,00 %	1	99	05/6/2026
1,00	1,71	2,74	2,33	2,225	0,36	18,27 %	1	35	05/6/2026
1,50	0,96	3,45	2,09	2,205	0,00	0,00 %	0	51	-
2,00	0,75	1,94	1,61	1,345	0,00	0,00 %	0	11	-
2,50	0,52	0,80	0,67	0,66	-0,53	-44,17 %	23	4	05/6/2026
3,00	0,30	0,43	0,31	0,365	-0,36	-53,73 %	1 331	188	05/6/2026
3,50	0,08	0,13	0,14	0,105	-0,16	-53,33 %	10 829	12 809	05/6/2026
4,00	0,03	0,05	0,04	0,04	-0,08	-66,67 %	2 393	2 960	05/6/2026
4,50	0,05	0,04	0,02	0,045	-0,02	-50,00 %	591	1 311	05/6/2026
5,00	0,01	0,04	0,02	0,025	0,00	0,00 %	61	791	05/6/2026
5,50	0,00	0,47	0,02	0,02	0,00	0,00 %	0	2	-
6,00	0,00	0,47	0,01	0,01	0,00	0,00 %	0	3	-
7,00	0,00	0,87	0,00	0,00	0,00	0,00 %	0	0	-

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Ventes

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
0,50	0,00	0,01	0,07	0,07	0,00	0,00 %	0	21	-
1,00	0,00	0,01	0,01	0,01	-0,01	-50,00 %	1	1	05/6/2026
1,50	0,00	0,30	0,00	0,00	0,00	0,00 %	0	0	-
2,00	0,00	0,09	0,06	0,06	0,00	0,00 %	0	1	-
2,50	0,00	0,09	0,09	0,09	0,00	0,00 %	0	12	-
3,00	0,04	0,17	0,15	0,105	0,11	275,00 %	184	815	05/6/2026
3,50	0,36	0,54	0,36	0,45	0,22	157,14 %	103	202	05/6/2026
4,00	0,62	1,15	0,89	0,885	0,39	78,00 %	12	7	05/6/2026
4,50	0,75	1,89	1,00	1,32	0,00	0,00 %	0	12	-
5,00	0,74	3,70	1,39	2,22	0,00	0,00 %	0	13	-
5,50	1,72	2,80	0,00	2,26	0,00	0,00 %	0	0	-
6,00	1,80	4,00	2,77	2,90	0,00	0,00 %	0	1	-
7,00	2,70	4,50	0,00	3,60	0,00	0,00 %	0	0	-

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
SCAGScage Future	US$ 0,8489 (196,61%)	92,75M
SPHLSpringview Holdings Ltd	US$ 5,38 (125,20%)	40,61M
NOTVInotiv Inc	US$ 0,1638 (89,15%)	1,07B
RMSGReal Messenger Corporation	US$ 1,809 (64,45%)	199,97M
STISolidion Technology Inc	US$ 35,50 (56,32%)	38,55M
NUWENewellis Inc	US$ 0,1625 (-62,30%)	50M
NYXHNyxoah SA	US$ 1,41 (-51,04%)	2,47M
CYPHCypherpunk Technologies Inc	US$ 0,5176 (-47,26%)	30,53M
TDICDreamland Ltd	US$ 0,2277 (-37,68%)	12,09M
FOFOHang Feng Technology Innovation Co Ltd	US$ 3,91 (-36,73%)	381,9k
NOTVInotiv Inc	US$ 0,1638 (89,15%)	1,07B
SNBRSleep Number Corporation	US$ 0,477 (36,25%)	305,13M
SMTKSmartKem Inc	US$ 0,419101 (30,97%)	232,19M
NVDANVIDIA Corporation	US$ 205,10 (-6,20%)	220,65M
RMSGReal Messenger Corporation	US$ 1,809 (64,45%)	199,97M

Lve

Lve il y a 4 minutes

What do you think the price will go to?

joe botts

joe botts il y a 4 minutes

prowler3701

prowler3701 il y a 4 minutes

Are we still in the quiet period?? LOL!!

Are we still the game changing, jaw dropping, next Lionsgate, tentpole movie, myflix tail that wags the dog, unbelievable movie distributor lol.

17 years of failure buffoon boy CEO.

Jack Wagon CEO!!

richme

richme il y a 4 minutes

Guess there is the problem of numbers in the clientele realm??

flipper44

flipper44 il y a 5 minutes

It’s been half a year since the ASM. It’s been two decades since the phase iii trial appeared on clinicaltrials.gov.

It’s great they are all around the world advocating for cancer vaccines, but we need an update. We need approval.

MHRA/NWBO have taken long enough.

Lve

Lve il y a 5 minutes

DewDiligence

DewDiligence il y a 6 minutes

PFE Berobenatide—dosed monthly—appears to be competitive with Zepbound and Wegovy—dosed weekly—in terms of efficacy and tolerability—see slide 7 at the link in #msg-177679183.

US Market News

US Market News il y a 6 minutes

Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complicationsJune 6, 2026 2:30 PM
PR Newswire (US)

DewDiligence

DewDiligence il y a 7 minutes

Berobenatide—dosed monthly—appears_ competitive_with_weekly Zepbound and Wegovy in_terms_of efficacy and tolerability—see slide 7 at the link in #msg-177679183.

janice shell

janice shell il y a 7 minutes

It’s about time!!

GeorgSchreiberEU

GeorgSchreiberEU il y a 10 minutes

Interesting development:

MSN has updated the name (not the ticker symbol) ... while OTC website still shows Natama

https://www.msn.com/en-us/money/stockdetails/fi-b19gfr?ocid=msedgntp&id=b19gfr

Rattlershehe

Rattlershehe il y a 12 minutes

Well, 55 his to skinny. Sigma pharmaceuticals was not in our wheelhouse. As an advisor to the company, the easiest way that I could say is. The whole Sigma thing went south as soon as the books needed to be audited. They did not want anyone in their business.
Methylene blue came into the pic

brazen22

brazen22 il y a 13 minutes

The “as quickly as possible” versus “as many as possible” framing has a problem.

If someone had GBM 2.5 years ago, I doubt they would view delay as acceptable because it might help reach more patients later. For the current GBM population, the fastest path matters.

Appr

mascale

mascale il y a 13 minutes

Qatar (royals) famous for recent lawful outcomes.

TightCoil

TightCoil il y a 14 minutes

Pulte Related? or Not?
IC3: Industry Alerts
Safeguarding Our Secrets
https://www.ic3.gov/CSA/2026/260603.pdf
June 3, 2026
Full Press Release

________________________________________

Ssgiants89

Ssgiants89 il y a 17 minutes

Did anyone else catch the NBA championship game? I saw Jalen Brunson was wearing some type of venom gear to help with pain. I looked it up. It looks like it operates with heat and vibration. We need to send this man and actipatch!!

chumfm

chumfm il y a 18 minutes

They are issuing millions of shares to cover their ATM.You will see upon completion a RS to move the price back to compliance.Check out CHR,same buyout,non-binding,and they formed a committee to look at the offer.Still no response and they already did a RS,after issuing millions of more shares.They

iateclube

iateclube il y a 18 minutes

"The name and the material are called Liquidmetal' .... which Apple may or may not ever use. I agree with you though, they would probably want to use it even though Apple is funny about any outside name association. At the same time, liquidmetal is recognized as a generic substance. I suppose t

IhidfromtheX

IhidfromtheX il y a 19 minutes

Well then in that case, we "should" be seeing revenue's! Are the sales going good in Europe?

peafunke

peafunke il y a 19 minutes

https://dataintelo.com/report/concert-live-streaming-market
Always thought that was a bit high. Nevertheless sure. But that’s not how you debut an app and grow / retain users. Eventually it will be a piece of the pie.
Less go

Timing101

Timing101 il y a 20 minutes

$SRXH I have posted in some time, but holding strong and added this past week again . all good here. The DD is strong , not going by all the IMO (in my opinion) folks out there, just the facts, disclosures and potential.

trusttheman

trusttheman il y a 21 minutes

Go Knicks and go Tptw!!!!! Suck it doubters!!!!

1manband

1manband il y a 21 minutes

"We are tired of this nonsense"

There Are Millions of Crypto Tokens. Almost None Have Any Value

https://finance.yahoo.com/markets/crypto/articles/millions-crypto-tokens-almost-none-150000991.html

Charles Hoskinson is angry.

The founder of C

my3sons87

my3sons87 il y a 21 minutes

There are a few reasons why Simply Wall St articles about a company such as InterDigital can appear disproportionately negative, even when the underlying platform is not intentionally bearish.

My assessment is that the apparent negativity is more likely a consequence of rule-based and

magikalalpha

magikalalpha il y a 22 minutes

https://x.com/DeborahHat96840/status/2063322755949273163?s=20

Processa Pharmaceuticals

Fidelity National Financ...

Dimensional Internationa...

KOSPI 200 Leverage 1.5x

Commercial Metals

First Trust Growth Stren...

BlackRock Investment Man...

Advanced Share Registry

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

ADVFN

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.